Eric T. Payne, MD, MPH, FRCP(C),Pediatric doctor of Neurocritical Care & Epilepsy at the Alberta Children’s Hospital and Assistant Professor of Pediatrics & Neurology, the University of Calgary, wrote and open letter outlining 10 arguments opposing the vaccine mandates for doctors in Alberta and draws the following conclusion; that blatant medical censorship is negatively impacting our profession, and our ability to make informed policy which is clearly people’s health and lives at risk.
- Even with 100% forced compliance – you cannot eradicate SARS-CoV-2 through vaccination.
- Is it really the unvaccinated driving SARS-CoV-2 virus mutations?
- As the effectiveness of mRNA vaccines to prevent transmission and severe disease continues to diminish – the medical narrative for a forced vaccine mandate evaporated.
- Natural immunity from SARS-CoV-2 is more durable and robust than the partial immunity achieved from the current mRNA vaccines.
- From a long-term safety perspective, these novel mRNA vaccines should be treated as guilty until proven otherwise, especially in low-risk groups.
- Children are at very low risk from COVID-19 infection itself, and rarely suffer severe disease and death
- Are we following the science?
- Is it possible that antibody dependent enhancement (ADE) is contributing in some people to the aggressive Delta outbreaks seen in Israel, India and … Calgary?
- Three Relevant Examples of Egregious Censorship and Misinformation.
- Without a mRNA vaccine, MY RISK TO PATIENTS does NOT increase
Read his entire bold, open letter HERE.
4. Shuster E. Fifty years later: The significance of the Nuremberg code. New England Journal of Medicine. 1997; 337:1436-1440.
5. Polack FP, Thomas SJ, Kitchin N, et al. Safety and Efficacy of the BNT162b2 mRNA Covid-19 vaccine. New England Journal of Medicine. 2020;383(27):2603-2615.
7. Baden LR, El Sahly HM, Essink B, et al. Efficacy and Safety of the mRNA-1273 SARSCoV-2 Vaccine. New England Journal of Medicine. Published online Dec 30, 2020. doi:10.1056/NEJMoa2035389
8. Product monograph, Moderna COVID-19 Vaccine.
11. Canada COVID-19 statistics.
12. Alberta government COVID-19 statistics.
13. Hannah Ritchie et al., 2020. – “Coronavirus Pandemic (COVID-19)”. Published online at OurWorldInData.org. Retrieved from: ‘https://ourworldindata.org/coronavirus’ [Online Resource].
14. Belongia & Naleway. Smallpox vaccine: the good, the bad, and the ugly. Clinical Medicine and Research. 2003: 1 (April): 87-92.
15. Palmer et al. Susceptibility of White-Tailed Deer (Odocoileus virginianus) to SARS-CoV-2. Journal of Virology. June 2021. 95(11): 1-16.
16. Le Bert N, et al. SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls. Nature. August 20, 2020. Vol 854.
17. Puranik A, Lenehan PJ, Silvert E, et al. Comparison of two highly-effective mRNA vaccines for COVID-19 during periods of Alpha and Delta variant prevalence. [Preprint posted online August 9, 2021].
18. Holmes et al. Understanding the mechanisms and drivers of antimicrobial resistance. Lancet 2016: 387:176-87.
19. Krause et al. SARS-CoV-2 variants and vaccines. New England Journal of Medicine. Jun 23 2021. DOI: 10.1056/NEJMsr2105280
20. Delta infection resulted in similar viral loads in vaccinated and unvaccinated individuals. Statement from CDC Director Rochelle P. Walensky, Friday July 30, 2021.
21. CDC Director – pandemic of the unvaccinated.
22. CDC Joint statement from HHS public health and medical experts on covid-19 booster shots. Wednesday August 18, 2021.
23. Nanduri S, Pilishvili T, Derado G, et al. Effectiveness of Pfizer-BioNTech and Moderna Vaccines in Preventing SARS-CoV-2 Infection Among Nursing Home Residents Before and During Widespread Circulation of the SARS-CoV-2 B.1.617.2 (Delta) Variant — National Healthcare Safety Network, March 1–August 1, 2021. MMWR Morb Mortal Wkly Rep 2021;70:1163-1166. DOI:
24. WHO statement.
25. FDA development and licensure of vaccines to prevent covid-19 guidance for industry.
26. Seppala E, et al. Vaccine effectiveness against infection with the Delta (B.1.617.2) variant, Norway, April to August 2021. Euro Surveill. 2021;26(35). https://doi.org/10.2807/1560- 7917.ES.2021.26.35.2100793.
30. Gaebler C et al., Evolution of antibody immunity to SARS-CoV-2, Nature. 2021 March; 591(7851): 639-644.
31. Gazit et al. Comparing SARS-CoV-2 natural immunity to vaccine-induced immunity: reinfections versus breakthrough infections. Pre-print HERE.
32. Reinfection rates Israel.
33. Jain, S et al. COVID-19 vaccination-associated myocarditis in adolescents. Pediatrics. 2021. DOI: 10.1542/peds.2021-053427
34. Ogata et al. Circulating severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine antigen detected in the plasma of mRNA-1273 vaccine recipients. Clinical Infectious Diseases. 2021;XX(xx):1-4. DOI: 10.1093/cid/ciab465
35. Cines DB & Bussel JB. SARS-CoV-2 Vaccine-Induced Immune Thrombotic Thrombocytopenia. New England Journal of Medicine. 2021. 384;23.
36. Verdecchia et al. The pivotal link between ACE2 deficiency and SARS-CoV-2 infection. European Journal of Internal Medicine. 2020. 76:14-20. https://doi.org/10.1016/j.ejim.2020.04.037.
37. Zhang et al. SARS-CoV-2 crosses the blood-brain barrier accompanied with basement membrane disruption without tight junctions alteration. Signal Transduction and Targeted Therapy. 2021. 6:337. https://doi.org/10.1038/s41392-021-00719-9.
38. Rhea et al. The S1 protein of SARS-CoV-2 crosses the blood-brain barrier in mice. Nature Neuroscience. Mar 2021. Vol 24: 368-378.
39. Pfizer Japan biodistribution rat studies:
40. Bojkova et al., Proteomics of SARS-CoV-2-infected host cells reveals therapy targets. Nature. 2020 Jul;583(7816):469-472.
41. Sharma et al. Comparative transcriptomic and molecular pathway analyses of HL-CZ human promonocytic cells expressing SARS-CoV-2 spike S1, S2, NP, NSP15 and NSP16 genes. Microorganisms. 2021, 9(1193): 1-27.
42. Idrees D & Kumar V. SARS-CoV-2 spike protein interactions with amyloidogenic proteins: Potential clues to neurodegeration. Biochemical and Biophysical Research Communication. 2021. 554:94-98.
43. Children and COVID-19: State Data Report. A joint report of the American Academy of Pediatrics and the Children’s Hospital Association. Version 9/2/21. https://downloads.aap.org/AAP/PDF/AAP%20and%20CHA%20-%20Children%20and%20COVID19%20State%20Data%20Report%209.2%20FINAL.pdf
44. Lu et al. SARS-CoV-2 infection in children. New England Journal of Medicine. 382;17. Apr 2020. DOI: 10.1056/NEJMc2005073
45. Feldstein et al. Multisystem inflammatory syndrome in U.S. Children and Adolescents. New England Journal of Medicine. July 23, 2020. 383(4): 334-346.
46. Lin J, et al. Neurological issues in children with COVID-19. Neuroscience Letters. 743(2021) 135567.
48. Heavey et al. No evidence of secondary transmission of COVID-19 from children attending school in Ireland, 2020. Euro Surveill. 2020;25(21):pii=2000903.
49. Gudbjartsson DF et al. Spread of SARS-CoV-2 in the Icelandic population. New England Journal of Medicine. 2020; (April):14. PMID: 32289214.
50. Lavezzo et al. Suppression of COVID-19 outbreak in the municipality of Vo, Italy. medRxiv.
51. Lachassine et al. SARS-CoV-2 transmission among children and staff in daycare centres during a nationwide lockdown in France: a cross-sectional, multicentre, seroprevalence study.
52. COVID-19 in schools and early childhood education and care services – the Term 3 experience n NSW. https://www.ncirs.org.au/sites/default/files/2020-10/COVID19%20Transmission%20in%20educational%20settings%20in%20NSW%20Term%203%20report_ 0.pdf
55. Lazarus et al. Electronic support for public health – vaccine adverse event reporting system (ESP:VAERS) https://digital.ahrq.gov/sites/default/files/docs/publication/r18hs017045-lazarusfinal-report-2011.pdf
56. Moro et al. Death Reported to the Vaccine Adverse Event Reporting System, United States, 1997-2013. Clinical Infectious Disease. September 2015; 61(6): 980-987.
57. https://www.ronjohnson.senate.gov/2021/8/sen-johnson-to-federal-health-agenciesexpediting-approval-process-appears-to-serve-the-political-purpose-of-imposing-and-enforcingvaccine-mandates 58. CDC and rotavirus vaccine. https://www.cdc.gov/mmwr/preview/mmwrhtml/mm5334a3.htm
59. Dr. Fauci comments re vaccine in kids. https://www.cnn.com/2021/08/30/health/uscoronavirus-monday/index.html
62. Huffington Post.
63.“COVID-19 Vaccines and Kids” link at www.19toZERO.ca https://drive.google.com/file/d/17cuUHAFhotVNipLtdAkHIQw4GfP72dUG/view.
64. Dr. Martin Kulldorff (Harvard), Dr. Sunetra Gupta (Oxford) and Dr. Jay Bhattacharya (Stanford). Great Barrington Declaration. 2020. https://gbdeclaration.org/ 6
5. Epoch TV, American Thought Leaders, August 10, 2021, interview with Dr. Martin Kulldorff. Link to full video. (Instead of fact checking or using Wikipedia – please listen to Dr. Kulldorff speak!)
66. Wan et al., Molecular mechanisms for antibody-dependent enhancement of coronavirus entry. Journal of Virology. March 2020, Volume 94 (5) e02015-19. 67. Lee et al., Antibody-dependent enhancement and SARS-CoV-2 vaccines and therapies. Nature Microbiology. Oct 2020, Vol 5. 1185-1191.
68. Vennema et al. Early death after feline infectious peritonitis virus challenge due to recombinant vaccinia virus immunization. Journal of Virology. Mar 1990. 64(3): 1407-1409.
69. Liu L et al. Anti-spike IgG causes severe acute lung injury by skewing macrophage responses during acute SARS-CoV infection. JCI Insight. 2019. 4:e123158.
70. Wang Q et al. Immunodominant SARS coronavirus epitopes in humans elicited both enhancing and neutralizing effects on infection in non-human primates. ACS Infectious Disease. 2016. 2:361-376.
71. Tseng et al. Immunization with SARS coronavirus vaccines leads to pulmonary immunopathology on challenge with the SARS virus. PLOS one. 2012. 7(4): e35421.
72. Luo F et al. Evaluation of antibody-dependent enhancement of SARS-CoV infection in rhesus macaques immunized with an inactivated SARS-CoV vaccine
73. Qin et al. Immunogenicity and protective efficacy in monkeys of purified inactivated Vero-cell SARS vaccine. Vaccine. 2006. 24:1028-1034.
74. Chau N, et al. Transmission of SARS-CoV2 Delta variant among vaccinated healthcare workers, Vietnam. Lancet preprints. https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3897733
75. Yahi N, et al. Infection-enhancing anti-SARS-CoV-2 antibodies recognize both the original Wuhan/D6414G strain and Delta variants. A potential risk for mass vaccination? Journal of Infection. Pre-print. On-line August 16, 2021.
78. Andersen K et al. The proximal origin of SARS-CoV-2. Nature Medicine. April 2020. Vol 26. 450- 455.
79. Yan L-M, Kang S, Hu S. Unusual features of the SARS-CoV2 genome suggesting sophisticated laboratory modification rather than natural evolution and delineation of its probable synthetic route. Available on Research Gate Sept 2020 here.
80. RETRACTED – Mehra et al., Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis. Lancet. May 22, 2020.
81. RETRACTED – Mehra M., et al. Cardiovascular disease, drug therapy, and mortality in covid-19. New England Journal of Medicine. June 25, 2020; 382:2582.
82. “Trust WHO” documentary film featuring 7-year investigation into the independent practices of the WHO and infiltration of non-public money. Directed by Lilian Franck. Highlights the 2009 H1NI flu pandemic. Film allegations were proven in court, yet YouTube continues to censor the film. 9 min video trailer link. (If link removed, search for “vimeo removes our film “trustWHO”).
83. Walensky warns of “pandemic of the unvaccinated”. Friday July 16, 2021.
84. Provides link to multiple MSM stories and videos of healthcare workers globally refusing the mRNA shots.